Pontecorvo, Michael J.
Arora, Anupa K.
Devine, Marybeth
Lu, Ming
Galante, Nick
Siderowf, Andrew
Devadanam, Catherine
Joshi, Abhinay D.
Heun, Stephen L.
Teske, Brian F.
Truocchio, Stephen P.
Krautkramer, Michael
Devous, Michael D. Sr.
Mintun, Mark A.
Article History
Received: 4 August 2016
Accepted: 16 December 2016
First Online: 7 January 2017
Compliance with ethical standards
:
: The authors are employees of Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company. 18F-Florbetapir (Amyvid®) is an Eli Lilly product.
: No new human subjects were involved in the study reported here. The quantitative analyses described here were performed on data from a previous study, which was performed in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.